Caton, M. Travis Jr. http://orcid.org/0000-0003-1581-7702
Mark, Ian T.
Narsinh, Kazim H.
Baker, Amanda
Cooke, Daniel L.
Hetts, Steven W.
Dowd, Christopher F.
Halbach, Van V.
Higashida, Randall T.
Ko, Nerissa U.
Chung, Sharon A.
Amans, Matthew R.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R56HL149124-01)
Article History
Received: 4 February 2022
Accepted: 6 April 2022
First Online: 3 May 2022
Declarations
:
: M. T. Caton Jr., I. T. Mark, K. H. Narsinh, A. Baker, D. L. Cooke, S. W. Hetts, C. F. Dowd, V. V. Halbach, R. T. Higashida, N. U. Ko, S. A. Chung and M. R. Amans declare that they have no competing interests. Amans (unrelated): Board membership: Mind Rhythm; Consultancy: Stryker Neurovascular, Covidien, MicroVention, Comments: Pipeline proctor for Covidien and PHIL DSMB for MicroVention; Patents (planned, pending or issued): Cerebral venous sinus stent, Comments: provisional patent serial number 62/984,549. Dowd (unrelated): Chief Adjudicator for EVOLVE Flow Diverter trial. Department salary support Stryker.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.